Dyslipidemia, particularly types IIA and IIB, is associated with an imbalance between cellular proliferation and apoptosis in lymphocytes of males with early chronic brain ischemia.
Answers are grounded in this paper and cite their sources.
Dyslipidemia-associated lymphocyte imbalance in ICBI warrants no practice change; leaves open causal immune mechanisms for prospective study.
Incidence of different types of dislipoproteinemias (DLPs) and a balance between apoptosis and proliferation of lymphocytes were studied in males exhibiting initial manifestations of cerebral blood flow insufficiency (ICBI). In general, high intensity of lymphocyte activation was revealed in patients with ICBI, with amplified proliferative potential demonstrable in this group. We have also shown a trend to increased numbers of T and B lymphocytes expressing antiapoptogenic bcl-2 protein. The changes in apoptosis and cell proliferation intensity were more pronounced in IIA and IIB types of DLP. In these groups, unidirectional changes of FasR expression were observed. However, the parameters reflecting readiness to apoptosis were changed multidirectionally. Cholesterol and oxysterols transported to the cells under excessive dyslipidemia may influence activities of transcription factor genes (bcl-2, Fas-regulatory gene (TDAG51), thus, probably, causing an imbalance between cellular proliferation and apoptosis.
No takes yet. Share an insight, caveat, or question.
Zurochka et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: